This episode, titled Optimizing Subcutaneous Therapies in NSCLC: Practical Integration, Patient Selection, and Workflow ...
Vietnam Investment Review on MSN
Celltrion launches AVTOZMA subcutaneous formulation in US
INCHEON, South Korea, March 16, 2026 /PRNewswire/ -- Celltrion, Inc. today announced that AVTOZMA® (tocilizumab-anoh) ...
SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...
Like many doctors, I often encountered patients suffering from musculoskeletal pain who had tried a variety of allopathic and natural treatment modalities with limited or no success. In many cases, I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results